More on INBX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+2.7% Growth)
- Ratings (8.3 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Inhibrx Inc. (NQ:INBX)
Delayed: 87.39 -1.68 (1.89%)
Prev. Close $89.07  
Open$86.68 
52 Wk High$ 
52 Wk Low$ 
Day High$91.52 
Day Low$85.21 
P/E N/A  
EPS$ 
Volume272,117 

Friends, Peers and Foes (?): ACET, ACRV, ARVN, AZN, BCAB (more...)

Jul 16, 2026 04:06 PM Form 8-K Inhibrx Biosciences, For: Jul 15
Jul 16, 2026 09:01 AM Inhibrx expands loan facility with Oxford Finance to $500M
Jul 16, 2026 09:01 AM Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million
Jun 15, 2026 04:07 PM Form 8-K Inhibrx Biosciences, For: Jun 15
Jun 15, 2026 09:15 AM Inhibrx receives FDA acceptance for ozekibart drug application
Jun 15, 2026 09:15 AM Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma
Jun 4, 2026 05:29 PM Form 4 Inhibrx Biosciences, For: Jun 03 Filed by: Vuori Kristiina MD
Jun 4, 2026 05:29 PM Form 4 Inhibrx Biosciences, For: Jun 03 Filed by: Kayyem Jon Faiz
Jun 4, 2026 05:29 PM Form 4 Inhibrx Biosciences, For: Jun 03 Filed by: FORSYTH DOUGLAS
Jun 4, 2026 05:29 PM Form 4 Inhibrx Biosciences, For: Jun 03 Filed by: MANHARD KIMBERLY
View All Articles

Entities mentioned with INBX

View All Entities